Celsius (NASDAQ:CELH) Given New $38.00 Price Target at Roth Mkm

Celsius (NASDAQ:CELH) had its price target cut by Roth Mkm from $40.00 to $38.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Roth Mkm’s price objective suggests a potential upside of 22.94% from the company’s previous close.

A number of other brokerages also recently issued reports on CELH. Jefferies Financial Group cut their price objective on shares of Celsius from $53.00 to $48.00 and set a “buy” rating on the stock in a research report on Thursday, October 10th. B. Riley reduced their price target on Celsius from $50.00 to $47.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. LADENBURG THALM/SH SH lowered their price objective on Celsius from $72.00 to $68.00 and set a “neutral” rating for the company in a research report on Monday, October 21st. Truist Financial upped their target price on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a research report on Wednesday, October 16th. Finally, JPMorgan Chase & Co. assumed coverage on Celsius in a report on Thursday. They issued an “overweight” rating and a $37.00 price target for the company. One investment analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $51.17.

Celsius Stock Performance

CELH traded down $0.88 on Monday, hitting $30.91. The company had a trading volume of 3,445,535 shares, compared to its average volume of 6,177,750. The stock has a market capitalization of $7.26 billion, a price-to-earnings ratio of 42.86, a P/E/G ratio of 3.44 and a beta of 1.76. The stock has a fifty day moving average price of $30.05 and a 200-day moving average price of $41.17. Celsius has a 12-month low of $25.23 and a 12-month high of $99.62.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Arkadios Wealth Advisors grew its stake in shares of Celsius by 4.1% during the 2nd quarter. Arkadios Wealth Advisors now owns 7,256 shares of the company’s stock worth $414,000 after purchasing an additional 289 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in Celsius by 12.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,567 shares of the company’s stock valued at $147,000 after buying an additional 289 shares during the period. Assenagon Asset Management S.A. boosted its holdings in Celsius by 0.3% in the 3rd quarter. Assenagon Asset Management S.A. now owns 99,047 shares of the company’s stock worth $3,106,000 after buying an additional 337 shares during the last quarter. Arizona State Retirement System increased its stake in Celsius by 0.9% during the 2nd quarter. Arizona State Retirement System now owns 41,615 shares of the company’s stock worth $2,376,000 after buying an additional 375 shares in the last quarter. Finally, Signaturefd LLC raised its holdings in shares of Celsius by 48.3% during the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock valued at $36,000 after acquiring an additional 378 shares during the last quarter. 60.95% of the stock is owned by institutional investors and hedge funds.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.